Author:
Cai Hongkun,Zhao Jingyuan,Zhang Qiyue,Wu Heyu,Sun Yan,Guo Feng,Zhou Yingke,Qin Gengdu,Xia Wentao,Zhao Yuhan,Liang Xueyi,Yin Shilin,Qin Yang,Li Dan,Wu Heshui,Ren Dianyun
Funder
National Natural Science Foundation of China
Reference85 articles.
1. Heterogeneity and plasticity of cancer-associated fibroblasts in the pancreatic tumor microenvironment;Boyd;Semin. Cancer Biol.,2022
2. Facts and hopes in immunotherapy of pancreatic Cancer, clinical cancer research: an official journal of the American association for;Bockorny;Cancer Res.,2022
3. Antibody therapy in pancreatic cancer: mAb-ye we're onto something?, Biochimica et biophysica acta;Boland;Reviews on cancer,2021
4. Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer, nature reviews;Adiseshaiah;Clin. Oncol.,2016
5. Challenges and opportunities for pancreatic Cancer immunotherapy;Bear;Cancer Cell,2020